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Abstract
Background: Total white blood cell (WBC) count has been consistently shown to be an
independent risk factor and predictor for future cardiovascular outcomes, regardless of disease
status in coronary artery disease (CAD). The purpose of this study is to evaluate the relation-
ship between total WBC count and the presence, severity and extent of coronary atherosclerosis
detected in subjects undergoing multislice computed tomographic (MSCT) coronary angiogra-
phy for suspected CAD.
Methods: A total of 817 patients were enrolled in this cross-sectional study. Non-significant
coronary plaque was defined as lesions causing £ 50% luminal narrowing, and significant
coronary plaque was defined as lesions causing > 50% luminal narrowing. For each segment,
coronary atherosclerotic lesions were categorized as none, calcified, non-calcified and mixed.
All images were interpreted immediately after scanning by an experienced radiologist.
Results: An association between hypertension, diabetes mellitus, age, gender, hyperlipidemia,
smoking, total WBC counts and coronary atherosclerosis was found when patients were
grouped into two categories according to the presence of coronary atherosclerosis (p < 0.05).
Although plaque morphology was not associated with total WBC counts, the extent of coronary
atherosclerosis was increased with higher total WBC quartiles (p = 0.006). Patients with
critical luminal stenosis had higher levels of total WBC counts when compared to patients with
non-critical luminal narrowing (7,982 ± 2,287 vs 7,184 ± 1,944, p < 0.05).
Conclusions: Our study demonstrated that total WBC counts play an important role in
inflammation and are associated with the presence, severity and extent of coronary atheroscle-
rosis detected by MSCT. Further studies are needed to assess the true impact of WBC counts
on coronary atherosclerosis, and to promote its use in predicting CAD. (Cardiol J 2011; 18, 4:
371–377)
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Introduction
Cardiovascular diseases are the leading cause
of death world-wide [1]. Inflammation plays a pivo-
tal role in the progression of atherosclerosis, and
white blood cell (WBC) count is a marker of inflam-
mation that is widely available in clinical practice
[2, 3]. Leukocytosis affects coronary artery disease
(CAD) through multiple pathological mechanisms
relevant to inflammation, oxidative damage to the
endothelial cells, microvasculature and hypercoa-
gulability.
In recent years, numerous epidemiological pro-
spective and retrospective cohort and case-control
studies have demonstrated that leukocytosis is an
independent predictor of future cardiovascular
events, both in healthy individuals free of CAD and
in subjects with CAD [3, 4]. Kostis et al. [5] stated
that patients with angiographically documented
CAD had higher leukocyte counts than patients
lacking CAD and that WBC count was an indepen-
dent marker of CAD severity after adjusting for car-
diovascular risk factors such as age, gender, total
cholesterol, triglyceride level and smoking. Corre-
lation of the leukocyte count with CAD and inves-
tigations into the utility of the leukocyte count as
a risk factor and prognostic indicator in patients with
CAD are consistent with the current concept that
atherosclerosis is an inflammatory disease.
To the best of our knowledge, there is no pub-
lished data on the relationship between the total
leukocyte count and coronary atherosclerosis de-
tected by dual-source multislice computed tomo-
graphy (MSCT) coronary angiography, which has the
advantage of showing atherosclerotic plaques in the
vessel wall in addition to luminal stenosis. In this
study, we assess the relationship between total
WBC count and the presence, severity and extent
of atherosclerotic lesions in patients undergoing
MSCT coronary angiography with suspected CAD.
Methods
Study sample and risk factor assessment
This cross-sectional study was performed in
a subset of patients admitted to our Cardiology De-
partment for cardiovascular evaluation between
January 2007 and June 2008 and in whom MSCT
coronary angiography was performed for suspect-
ed CAD.
Subjects with documented CAD, history of myo-
cardial infarction, presence of renal dysfunction (cre-
atinine ≥ 1.5 mg/dL), hepatic disorders, concomi-
tant inflammatory diseases, neoplastic diseases or
any systemic disorders, acute or chronic infectious
disease, or on medications which can affect leuko-
cyte counts were excluded from the study.
All subjects provided details of their back-
ground, medical history, and any medication they
were using at the time of clinical consultation. We
carried out a complete physical examination for each
patient. Diabetes was defined as a fasting plasma
glucose level ≥ 126 mg/dL or current diabetes treat-
ment with dietary modification, oral glucose-low-
ering agents, or insulin [6]. Hypertension was de-
fined as use of blood pressure medication or sys-
tolic blood pressure ≥ 140 mm Hg or diastolic blood
pressure ≥ 90 mm Hg. Hyperlipidemia was defined
as total cholesterol ≥ 200 mg/dL or treatment with
a lipid-lowering agent. Global CAD risk was esti-
mated by Framingham risk equation [7]. Complete
blood count, blood biochemistry and lipid profile
were taken from each patient. This study was ap-
proved by the local ethics committee and informed
consent was received from each participant.
Blood sample collection, measurement of
biochemical markers and leukocyte counts
Venous blood samples were obtained by veni-
puncture of the large antecubital veins. Blood sam-
ples were taken after overnight fasting and the se-
rum was centrifuged at 2,000 rpm for 10 min at 4oC.
The serum levels of triglyceride, total, low-density
lipoprotein-cholesterol and high-density lipopro-
tein-cholesterol and fasting glucose were deter-
mined enzymatically with a commercially available
assay kit (Hitachi P800, Holliston, Massachusetts,
USA). A complete blood count analysis including
leukocytes was performed within two hours of col-
lection as a laboratory policy of the hospital using
a Beckman Coulter (High Wycombe, UK) Gen-S
automated analyzer.
Coronary MSCT angiography
All subjects underwent computed tomography
coronary angiography imaging using dual-source
MSCT scanner (Somatom Definition, Siemens, Er-
langen, Germany). Sublingual nitrate (5 mg of iso-
sorbide dinitrate, Fako, Isordil) was given 2–4 min
before image acquisition to dilate the coronary ar-
teries. The coronary angiographic scan was ob-
tained with injection of 80 mL nonionic contrast
medium (350 mg I/mL iohexol, Amersham Health
Omnipaque) at a flow rate of 6 mL/s followed by
50 mL of saline solution with the same injection rate
to wash out the contrast material from the right
ventricle. Contrast administration was controlled
with bolus tracking. Scan parameters were: detec-
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tor collimation, 32 × 0.6 mm; slice acquisition,
64 × 0.6 mm; gantry rotation time, 330 ms; tempo-
ral resolution, 83 ms; pitch, 0.2–0.47 adapted to the
heart rate; tube current, 390 mAs per rotation; tube
potential, 120 kV. Scanning time was 5.7–8.4 s,
depending on the cardiac dimensions and pitch, in
a single breathhold in the craniocaudal direction.
Prospective ECG tube-current modulation (ECG
pulsing) for radiation dose reduction was used for
all patients. Retrospective gating technique was
used to synchronize data reconstruction with the
ECG signal. Best systolic and diastolic reconstruc-
tions were made in all patients at a slice thickness
of 0.75 mm and a reconstruction increment of
0.5 mm. The reconstruction with the fewest motion
artifacts was chosen and used for further analysis.
MSCT evaluation
All images were interpreted immediately after
scanning by an experienced radiologist unaware of
the clinical presentation of the patients. Coronary
plaque was defined as any clearly discernible struc-
ture attributable to the coronary artery wall in at
least two independent image planes. Non-significant
coronary plaque was defined as lesions causing
£ 50% luminal narrowing, and significant coronary
plaque was defined as lesions causing > 50% lumi-
nal narrowing. All the coronary atherosclerotic
plaques were included in the analysis. For catego-
rization of the coronary plaques, the coronary sys-
tem was divided into 16 separate segments based
on a modified American Heart Association classifi-
cation using original axial images, thin slice, maxi-
mal intensity projections, and cross-sectional recon-
structions orthogonal to the long axis of each coro-
nary segment (0.75 mm thickness) [8]. For each
segment, coronary plaques were categorized as
(1) none, (2) calcified (defined as a CT density more
than the contrast enhanced coronary lumen),
(3) non-calcified (defined as a CT density less than
the contrast enhanced coronary lumen but greater
than the surrounding connective tissue), (4) mixed
(having both calcified and non-calcified components)
[9]. The extent of coronary atherosclerosis was cal-
culated as the sum of the affected coronary seg-
ments. All plaque components and significant steno-
sis were assessed per segment.
Statistical analysis
Continuous variables were expressed as mean
± SD and categorical variables were expressed as
percentages. Comparisons of categorical and con-
tinuous variables between the two groups were
performed using the c2 test and independent sam-
ples t test, respectively. Kruskal-Wallis test was
used to compare differences in mean values be-
tween groups where there were three or more in-
dependent groups. To determine independent pre-
dictors of presence and severity of coronary athero-
sclerosis, multiple logistic regression analysis was
performed by including the parameters, which were
significantly different between the groups. Statis-
tical analyses were performed using SPSS statisti-
cal software (version 15.0; SPSS Inc., Chicago, Illi-
nois, USA). A two tailed p < 0.05 was considered
statistically significant.
Results
Between January 2007 and June 2008, a total
of 817 patients who were admitted to our cardiolo-
gy department and underwent coronary MSCT an-
giography were enrolled in the study. Of these,
414 were male (50.7%), mean age ± SD 57.4 ±
± 11.6 years. Basal characteristics of the subjects
are shown in Table 1. Among the study population,
Table 1. Basal clinical characteristics of patients
enrolled in the study (n = 817).
Variable Mean ± SD
Age (years) 57.5 ± 11.2
Gender (male) 414
Hypertension 66.2%
Diabetes mellitus 18.2%
Dyslipidemia 63.6%
Smoking 31.1%
History of premature CAD 9.3%
Total cholesterol [mg/dL] 207.6 ± 44.7
Triglyceride [mg/dL] 157.6 ± 82.9
HDL cholesterol [mg/dL] 51.4 ± 15.5
LDL cholesterol [mg/dL] 131.0 ± 38.5
BMI [kg/m2] 27.9 ± 4.8
Total WBC count 7,438 ± 2,091
Framingham risk score:
Low risk 41.9%
Intermediate risk 35.5%
High risk 23.3%
Acetylsalycilic acid 63.3%
Beta-blocker 36.4%
Calcium channel blocker 14.6%
ACE inhibitor 20.3%
Angiotensin receptor blocker 33.0%
Statins 47.0%
ACE — angiotensin converting enzyme; BMI — body mass index;
CAD — coronary artery disease; HDL — high-density lipoprotein;
LDL — low-density lipoprotein; WBC — white blood cells
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66.2% had hypertension, 18.2% had diabetes mel-
litus, 63.6% had hyperlipidemia, 31.1% were smok-
ers, and 9.3% had a history of premature CAD in
their family.
An association between several cardiovascular
risk factors including hypertension, diabetes mel-
litus, age, gender, hyperlipidemia, smoking and
coronary atherosclerosis was found when patients
were grouped into two categories according to the
presence or absence of coronary atherosclerosis, as
shown in Table 2 (p < 0.05).
Patients having coronary atherosclerosis in
MSCT angiography had higher levels of serum leu-
kocyte counts when compared to subjects lacking
coronary atherosclerosis (7,657 ± 2,230 vs 7,078 ±
± 1,785; p < 0.001, respectively). Additionally, pa-
tients having critical luminal stenosis detected by
MSCT had higher levels of total WBC counts when
compared to patients having coronary atheroscle-
rosis but no critical luminal narrowing (7,982 ±
± 2,287 vs 7,184 ± 1,944; p < 0.05). Thus severity
of coronary atherosclerosis was also related to WBC
counts.
In the multiple logistic regression analysis
evaluating the relationship between WBC quartiles
and the presence of coronary atherosclerosis de-
tected by MSCT, patients were divided into quar-
tiles, with each quartile having a similar number of
subjects: 216, 199, 204 and 197. Leukocyte counts
were < 6,000, 6,000–7,200, 7,200–8,600 and  > 8,600,
respectively. Although being in the 1st, 2nd or
3rd quartile caused no significant increase in the risk
of the presence of coronary atherosclerosis detect-
ed by MSCT, being in the 4th quartile increased the
risk of coronary atherosclerosis by 1.8 times (odds
ratio [OR], 1.85; 95% confidence interval [CI], 1.15–
–2.96, p < 0.005). Apart from total WBC counts,
diabetes mellitus, gender, hyperlipidemia, smoking
and age were found to be significantly associated
with coronary atherosclerosis shown in logistic re-
gression analysis (Table 3). When critical luminal
stenosis was assumed, being in the 3rd or 4th quar-
tile increased the risk of detection of critical lumi-
nal stenosis by 1.9 and 2.5 times, respectively. For
the 3rd quartile: OR 1.9, 95% CI 1.2–3.0, p < 0.005;
and for the 4th quartile: OR 2.5, 95% CI 1.6–4.0,
p < 0.005 (Fig. 1). In addition to WBC quartiles,
gender, hyperlipidemia, smoking and age were also
found to be significantly associated with critical
coronary plaque (OR 2.4, 95% CI 1.7–3.5, p < 0.005,
OR 2.6, 95% CI 0.75–1.6, p < 0.005; OR 1.9, 95%
CI 1.3–2.7, p < 0.005; OR 1.1, 95% CI 1.0–1.18,
p < 0.005, respectively).
There was no relationship between the mor-
phology of coronary plaques and WBC quartiles when
plaque was classified as being exclusively calcified,
non-calcified or mixed (7,255 ± 2,302, 7,626 ± 1,966,
7,644 ± 2,158, p = 0.42, respectively) as shown in
Figure 2. The extent of coronary atherosclerosis was
Table 2. Comparison of patients with coronary plaque to patients without coronary plaque shown by
multislice computed tomography.
Cardiovascular risk factors Coronary plaque (–) (n = 308) Coronary plaque (+) (n = 509) P
Hypertension (%) 56.0 72.3 < 0.001
Diabetes mellitus (%) 11.1 22.6 < 0.001
Hyperlipidemia (%) 50.2 71.7 < 0.001
Smoking (%) 25.4 34.4 < 0.05
Fx CAD (%) 9.4 9.2 0.92
Age 51.2 ± 11.3 61.0 ± 10.2 < 0.001
Gender (male) (%) 43.6 55.0 < 0.05
Total WBC count 7,078 ± 1,785 7,657 ± 2,230 < 0.001
CAD — coronary artery disease; Fx CAD — family history of premature CAD; WBC — white blood cell
Table 3. Multivariate logistic regression analysis
demonstrating the association between cardio-
vascular risk factors including total WBC counts
and the presence of coronary plaque.
Variable OR 95% CI P
Age 1.09 1.07–1.11 < 0.001
Gender (male) 2.40 1.70–3.50 < 0.001
Hypertension 1.13 0.78–1.62 0.51
Diabetes mellitus 1.59 1.00–2.52 < 0.05
Smoking 1.16 0.80–1.69 < 0.05
Hyperlipidemia 2.14 1.53–3.00 < 0.05
WBC quartile 2 1.14 0.73–1.79 0.55
WBC quartile 3 1.16 0.74–1.82 0.49
WBC quartile 4  1.85 1.15–2.96 < 0.05
OR — odds ratio; CI — confidence interval; WBC — white blood cell
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also investigated according to the number of coro-
nary segments involved. Kruskal-Wallis analysis re-
vealed an association between the number of coro-
nary plaques involved and increasing WBC quartiles,
except the 2nd and 3rd quartiles (Fig. 3).
Discussion
Previous studies have shown that a higher to-
tal WBC count is a risk factor for CAD [5, 10, 11].
To the best of our knowledge, this is the first study
in the literature evaluating the relationship between
total WBC counts and coronary atherosclerosis
detected by MSCT, a method evaluating not only
luminal narrowing but also atherosclerosis at the
coronary artery wall which could not be shown by
conventional coronary angiography. Our study
found that total WBC counts were indepentently
associated with the presence and severity of coro-
nary atherosclerosis apart from other well-known
cardiovascular risk factors, and that this relation-
ship persisted after adjustment for multiple cardio-
vascular risk factors.
Inflammation is a key feature of atherosclero-
sis and its clinical manifestations, and total WBC
Figure 1. Association between the significant luminal stenosis and white blood cell (WBC) quartiles in multiple
logistic regression analysis, showing that being in the 3rd or 4th quartile increases the risk of critical luminal stenosis
detected by 1.9 and 2.5 times respectively with smoking, hyperlipidemia and age; *p < 0.05.
Figure 2. Frequency of plaque morphology according
to total white blood cell (WBC) quartiles; p > 0.05.
Figure 3. Association between total white blood cell
(WBC) quartiles and extent of coronary atherosclerosis
due to number of coronary segments involved (p = 0.006,
Kruskal-Wallis test).
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count is a marker of inflammation that is widely
available in clinical practice. Leukocytes affect the
development of CAD through multiple mechanisms
that mediate inflammation, cause proteolytic and
oxidative damage to the endothelial cells, plug the
microvasculature, induce hypercoagulability, and
promote infarct expansion [3]. Stimulated neutro-
phils are known to secrete proteolytic neutral pro-
teases, large amounts of chemotactic agents and
inflammatory mediators in patients with stable an-
gina [12].
Numerous epidemiological and clinical studies
have shown leukocytosis to be an independent pre-
dictor of  future cardiovascular events, both in
healthy individuals free of CAD at baseline and in
patients with CAD [13–16]. The role of a higher
WBC count as a coronary risk factor was assessed
in a case-control study of dyslipidemic middle-aged
men participating in the Helsinki Heart Study which
was a coronary primary prevention trial. Baseline
leukocyte count was significantly higher in subjects
with cardiovascular disease than in controls
(p < 0.002) [17]. In a retrospective study by Take-
da et al. [18] including the health-check records of
6,021 Japanese people without any cardiovascular
disease, baseline leukocyte counts of patients with
acute coronary syndrome were significantly high-
er than those of subjects without CAD (9.21 ± 2.70/
/µL vs 6.20 ± 1.63/µL, p < 0.001). The leukocyte
count was strongly associated with the prognosis
of patients who have had an myocardial infarction
within the previous three months. Several experi-
mental and pathological studies have suggested that
leukocytes play an important role in the destabili-
zation of coronary artery plaques and in causing
acute coronary syndrome initiation [19, 20]. Addi-
tionally, the blood leukocyte count has important
implications regarding the prognosis of CAD. In the
TACTICS–TIMI-18 (Treat Angina with Aggrastat
Plus Determine Cost of Therapy with an Invasive
or Conservative Strategy-Thrombolysis In Myocar-
dial Infarction-18) trial, among patients with unsta-
ble angina or non-ST-segment elevation myocardial
infarction, higher baseline WBC counts were asso-
ciated with poorer reperfusion, more extensive
CAD, and higher six-month mortality [21].
Our study found a correlation between coro-
nary atherosclerosis documented by MSCT and
total WBC counts, in a population suspected of ha-
ving, but without a previous history of, CAD. Be-
sides the presence of coronary plaque, total WBC
counts were also associated with the severity and
extent of coronary atherosclerosis. This may be an
important finding when the progression of inflam-
matory process evolving from non-critical plaque to
critical stenosis due to atherosclerosis is consi-
dered. In a study investigating the relationship be-
tween blood leukocyte counts and subclinical athe-
rosclerosis due to carotid intima-media thickness
by Loimaala et al. [22], higher blood leukocyte count
was associated with carotid artery wall thickening
in middle-aged Finnish men, supporting the hypo-
thesis that leukocytes play an independent role in
early vascular injury and atherogenesis. Therefore
our results are compatible with the role of blood
leukocyte counts in the atherosclerotic process.
The relationship between coronary artery cal-
cification and traditional cardiovascular risk factors
has been documented in previous reports [23].
Some have also suggested that non-calcified coro-
nary plaques detected by MSCT were associated
with acute coronary syndrome compared to calci-
fied plaques [24, 25]. In our study, the relationship
between the morphology of atherosclerotic plaque
and total WBC counts was also investigated, but
coronary plaque morphology was not found to be
associated with WBC quartiles. This may be due to
the risk profiles andpopulation characteristics of the
patients enrolled in the study, as well as to the as-
sociation of WBC counts with coronary atheroscle-
rosis irrespective of plaque morphology.
The main strength of our paper is that it is the
first report about the relationship between an in-
flammatory marker, total WBC, and coronary athe-
rosclerosis shown by MSCT which can demonstrate
early morphologic changes before clinical presen-
tation. However, the usefulness of total WBC count
as a surrogate marker for atherosclerosis has some
limitations. Firstly, although the study population
is free from documented CAD, this cohort has high-
er risk factors compared to the normal population,
as stated previously, because of being a selected
group of patients admitted for CAD evaluation. Sec-
ondly, this is a cross-sectional study and the aim
was to assess the association between leukocyte
count and coronary atherosclerosis. Therefore the
prognostic role of total WBC counts was not inves-
tigated. Thirdly, because of racial differences be-
tween the prevalence and extent of coronary athe-
rosclerosis, these findings cannot be extrapolated
to all populations [26]. Finally, biochemical analy-
sis did not include more precise markers of inflam-
mation and the analysis of plaque morphology was
limited by only one feature of the plaque architec-
ture, i.e. calcification, assessed by MSCT. It is still
open to debate whether thin fibrous cap, large lipid
core or extent of plaque vascularization correlate
with WBC count and other signs of inflammation.
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Conclusions
To summarize, because higher blood leukocyte
count was shown to be an independent risk factor
and prognostic indicator of future cardiovascular
outcomes, the association between higher total
WBC counts and the presence, severity and extent
of coronary atherosclerosis was confirmed in this
study. Because aggressive risk modification may be
beneficial in this subset of patients, further follow-
-up studies are needed to clarify the role of inflam-
matory markers and total WBC counts as a risk fac-
tor for atherosclerosis.
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